norflurane: Clinical Trials

7 trials of norflurane, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 3 recruiting, 1 terminated. 2 Phase 1, 2 Phase 2, 2 Phase 3, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Recruiting 1
Phase 22Recruiting 2
Phase 32Completed 1, Recruiting 1
Phase 42Completed 1, Terminated 1

Follow norflurane: new trials by email Literature Review of norflurane trials Research Report on norflurane

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)
HFA-152a, HFA-134a - Asthma
Phase 3RecruitingGlaxoSmithKline1102026-09-012026-11-05
Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma
CHF5993 pMDI with HFA-152a, CHF5993 pMDI with HFA-134a, CHF718 pMDI with HFA-134a - Asthma
Phase 2RecruitingChiesi Farmaceutici S.p.A.7802025-12-172026-06-25
Study of the Effect of HFA-152a and HFA-134a Propellants on Mucociliary Clearance in Healthy Participants
HFA-152a, HFA-134a, Radiolabeled saline solution - Asthma
Phase 1CompletedGlaxoSmithKline242024-07-292026-04-14
Advair HFA in Healthy and HAPE Predisposed Subjects
Advair HFA, Placebo - Altitude Edema
Phase 1 / Phase 2RecruitingUniversity of Colorado, Denver602023-12-122025-09-22
Study to Assess Effect of Next-Generation Propellant MDI on Mucociliary Clearance Vs. HFA Propellant MDI in Healthy Participants
HFO-1234ze(E), HFA-134a - Mucociliary Clearance
Phase 3CompletedAstraZeneca352023-06-142026-02-25
Enhancing Anaesthetic Success in Mandibular Molars With Symptomatic Irreversible Pulpitis: A Comparative Randomized Controlled Trial
Dexamethasone sodium phosphate injection, 1,1,1,2 tetrafluoroethane, intraoral soft tissue cryotherapy - Pulpitis - Irreversible
Phase 4CompletedAin Shams University1882023-02-012025-05-09
Vapocoolant Spray for Numbing Small Boils Before Incision and Drainage
Lidocaine, Vapocoolant - Abscess
Phase 4TerminatedAlbert Einstein Healthcare Network212012-08-012020-03-19

Conditions studied

Asthma (3)  ·  Abscess (1)  ·  Altitude Sickness (1)  ·  Bronchial Spasm (1)  ·  Furunculosis (1)  ·  Hypoxia (1)

Sponsors

GlaxoSmithKline (2)  ·  Ain Shams University (1)  ·  Albert Einstein Healthcare Network (1)  ·  AstraZeneca (1)  ·  Chiesi Farmaceutici S.p.A. (1)  ·  University of Colorado, Denver (1)

Countries

United Kingdom (4)  ·  United States (4)  ·  Argentina (2)  ·  Bosnia and Herzegovina (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  Czechia (1)  ·  Egypt (1)  ·  Germany (1)  ·  Hungary (1)  ·  Latvia (1)  ·  Mexico (1)  ·  Romania (1)  ·  Serbia (1)  ·  Slovakia (1)

Top investigators

Andreas Schmid, MD (1)  ·  Douglas Conrad, MD (1)  ·  James P Maloney, MD (1)  ·  Joseph D'Orazio, MD (1)  ·  Peter Mogayzel, MD, PhD, MBA (1)  ·  Timothy Corcoran, PhD (1)  ·  William D Bennett, PhD (1)

Results publications

PMID 42461285

NIH funding

2025 (1)